| Value | ₹17.00 Cr |
|---|
NSE filing, NSE: SRPL. Summary written from the filing by ALFA Finder's alert engine.
More from Shree Ram Proteins Limited
All →Shree Ram Proteins Q1 FY27 Results: Net Loss of ₹6.4 Cr, Loss Widens
Shree Ram Proteins Limited reported a net loss of ₹6.4 Cr for Q1 FY27.
- Key figure
- Net loss ₹6.4 Cr
Shree Ram Proteins Board Meeting Date
Shree Ram Proteins Limited scheduled a board meeting for 17-Aug-2026. The meeting will consider the company's unaudited financial results for the quarter ended June 2026.
Shree Ram Proteins Annual General Meeting
Shree Ram Proteins Ltd has issued a postal ballot notice seeking shareholder approval for the sale of its undertaking for an approximate consideration of ₹17 Crore.
- Value
- ₹17.00 Cr
Shree Ram Proteins Annual General Meeting
Shree Ram Proteins Limited has issued a postal ballot notice seeking shareholder approval for the sale or disposal of the whole or substantially the whole undertaking.
Shree Ram Proteins Board Meeting Date
Shree Ram Proteins Limited has rescheduled its board meeting to August 17, 2026. The meeting will discuss yearly audited financial results.
Shree Ram Proteins Board Meeting Date
Shree Ram Proteins rescheduled its board meeting to July 31, 2026. The meeting will consider audited standalone financial results for the year ended March 2026.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr